Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02052648
Title Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NewLink Genetics Corporation
Indications

brain glioblastoma multiforme

high grade glioma

gliosarcoma

Therapies

Temozolomide

Indoximod

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Eden Medical Center Castro Valley California 94546 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
UC Irvine Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University Cancer and Blood Center Athens Georgia 30607 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30342 United States Details
Augusta University Augusta Georgia 30912 United States Details
University of Chicago Chicago Illinois 60637 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
University of Kentucy Lexington Kentucky 40536 United States Details
John Nasseff Neuroscience Institute Minneapolis Minnesota 55407 United States Details
University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico 87131 United States Details
Wake Forest Baptist Health Comprehensive Cancer Center Winston-Salem North Carolina 27157 United States Details
Penn State Hershey Medical Center Hershey Pennsylvania 17033 United States Details
Texas Oncology Austin Texas 78705 United States Details
Huntsman Cancer Center Salt Lake City Utah 84112 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field